Abstract:The field of chemical toxicity testing is undergoing a transition to overcome the limitations of in vivo experiments. This evolution involves implementing innovative non-animal approaches to improve predictability and provide a more precise understanding of toxicity mechanisms. Adverse outcome pathway (AOP) networks are pivotal in organizing existing mechanistic knowledge related to toxicological processes. However, these AOP networks are dynamic and require regular updates to incorporate the latest data. Regulatory challenges also persist due to concerns about the reliability of the information they offer. This study introduces a generic Weight-of-Evidence (WoE) scoring method, aligned with the tailored Bradford-Hill criteria, to quantitatively assess the confidence levels in key event relationships (KERs) within AOP networks. We use the previously published AOP network on chemical-induced liver steatosis, a prevalent form of human liver injury, as a case study. Initially, the existing AOP network is optimized with the latest scientific information extracted from PubMed using the free SysRev platform for artificial intelligence (AI)-based abstract inclusion and standardized data collection. The resulting optimized AOP network, constructed using Cytoscape, visually represents confidence levels through node size (key event, KE) and edge thickness (KERs). Additionally, a Shiny application is developed to facilitate user interaction with the dataset, promoting future updates. Our analysis of 173 research papers yielded 100 unique KEs and 221 KERs among which 72 KEs and 170 KERs, respectively, have not been previously documented in the prior AOP network or AOP-wiki. Notably, modifications in de novo lipogenesis, fatty acid uptake and mitochondrial beta-oxidation, leading to lipid accumulation and liver steatosis, garnered the highest KER confidence scores. In conclusion, our study delivers a generic methodology for developing and assessing AOP networks. The quantitative WoE scoring method facilitates in determining the level of support for KERs within the optimized AOP network, offering valuable insights into its utility in both scientific research and regulatory contexts. KERs supported by robust evidence represent promising candidates for inclusion in an in vitro test battery for reliably predicting chemical-induced liver steatosis within regulatory frameworks.

The Cost Outcome Pathway Framework: Integrating socio-economic impacts to Adverse Outcome Pathways

The adverse outcome pathway concept: a pragmatic tool in toxicology

Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment

Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathways

The First Steps on AOPs' Concepts, Development, and Applications in Teratology

Adverse outcome pathways: opportunities, limitations and open questions

Harvesting the promise of AOPs: An assessment and recommendations

Adverse Outcome Pathway Networks II: Network Analytics.

A toxicity pathway-oriented approach to develop adverse outcome pathway: AHR activation as a case study

Crowdsourcing AOP development: Leveraging the thesis literature review to identify knowledge gaps and facilitate research translation

AOP report: Development of an adverse outcome pathway for deposition of energy leading to learning and memory impairment

Potential adverse outcome pathways with hazard identification of organophosphate esters

Proof of concept for quantitative adverse outcome pathway modeling of chronic toxicity in repeated exposure

From papers to RDF-based integration of physicochemical data and adverse outcome pathways for nanomaterials

Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework

Adverse Outcome Pathway for the Neurotoxicity of Per- and Polyfluoroalkyl Substances: A Systematic Review

The potential connections of adverse outcome pathways with the hazard identifications of typical organophosphate esters based on toxicity mechanisms

Chemical exposome and children health: Identification of dose-response relationships from meta-analyses and epidemiological studies

Developing adverse outcome pathways on silver nanoparticle-induced reproductive toxicity via oxidative stress in the nematode Caenorhabditis elegans using a Bayesian network model

A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: a case study on chemical-induced liver steatosis

Prediction of the Neurotoxic Potential of Chemicals Based on Modelling of Molecular Initiating Events Upstream of the Adverse Outcome Pathways of (Developmental) Neurotoxicity